Clinical And Translational Radiation Oncology

Clinical And Translational Radiation Oncology

临床和转化放射肿瘤学

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Clinical And Translational Radiation Oncology》是由Elsevier出版社创办的英文国际期刊(ISSN: 2405-6308,E-ISSN: 2405-6308),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Medicine-Radiology, Nuclear Medicine and Imaging。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA开放获取模式(OA占比%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比87.13%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在171篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical And Translational Radiation Oncology审稿周期约为28 Weeks。该刊近年未被列入国际预警名单,年发文量约171篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 171 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区 3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区 3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 132 / 333

60.5

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 51 / 217

76.7

学科:ONCOLOGY SCIE Q2 114 / 333

65.92

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 68 / 217

68.89

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 163 / 322

49.5

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 68 / 204

66.9

学科:ONCOLOGY SCIE Q2 121 / 322

62.58

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 73 / 204

64.46

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.7 SJR:1.248 SNIP:1.194
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 69 / 361

80%

大类:Medicine 小类:Oncology Q2 127 / 428

70%

期刊发文

  • Diagnostic CT-guided online adaptive radiotherapy for locally advanced colon cancer: a prospective implementation and feasibility stud

    Author: Zhao, Jun; Zhang, Hui; Yu, Lei; Hu, Yiwen; Yang, Yanju; Dong, Sixue; Mi, Jing; Fang, Yingtao; Qiao, Jian; Xia, Fan; Hu, Weigang; Zhang, Zhen

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 59, Issue , pp. -. DOI: 10.1016/j.ctro.2026.101162

  • Long-term Outcomes of Toxicities and Disease Control Following Postoperative Moderately Hypofractionated Radiotherapy in High-Risk Prostate Cancer: Results of a Prospective Stud

    Author: Ren, Xue-Ying; Qin, Shang-Bin; Liu, Chao; Qi, Xin; Bai, Yun; Chen, Jia-Yan; Lyu, Feng; Gao, Yan; Li, Xiao-Ying; Li, Hong-Zhen; Gao, Xian-Shu; Ma, Ming-Wei

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 59, Issue , pp. -. DOI: 10.1016/j.ctro.2026.101150

  • MonoHER selectively enhances the radiotherapy response in p53 wild-type breast cancer via stabilization of p5

    Author: Li, Chujie; Li, Xiaojun; Biemans, Rianne; Zhang, Ming; Dubois, Ludwig J

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 58, Issue , pp. -. DOI: 10.1016/j.ctro.2026.101147

  • Timing, fractionation, and dose of thoracic radiotherapy in patients with extensive-stage small cell lung cancer undergoing first-line Chemo-Immunotherap

    Author: Zhou, Hao; Zhao, Huan; Shi, Shuming; Hu, Tao; Li, Li; Wang, Shuai; Zhang, Zhe; Yuan, Shuanghu

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 58, Issue , pp. -. DOI: 10.1016/j.ctro.2026.101114

  • Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trial

    Author: Shen, Jingyi; Ai, Dashan; Chen, Yun; Liu, Qi; Deng, Jiaying; Hao, Shengnan; Zhang, Xiaofei; Zhang, Junhua; Zhang, Yutong; Chu, Li; Sun, Yihua; Zhang, Yawei; Xiang, Jiaqing; Miao, Longsheng; Chen, Haiquan; Zhu, Hongcheng; Zhao, Kuaile

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 57, Issue , pp. -. DOI: 10.1016/j.ctro.2025.101073

  • Differential regulation of radioadaptation by quercetin between human normal and cancer cell

    Author: Li, Chujie; Li, Xiaojun; Biemans, Rianne; Zhang, Rui; Zhang, Ming; Dubois, Ludwig J

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2026; Vol. 57, Issue , pp. -. DOI: 10.1016/j.ctro.2025.101099

  • SBRT in recurrent oligometastatic ovarian cancer: An EORTC Y-ECI GCG systematic revie

    Author: Huck, Constance; Kountouri, Melpomeni; Yarza, Ramon; Marquina, Gloria; Espantaleon, Manuel; Kroep, Judith; Herrera, Fernanda; Madariaga, Ainhoa; Sanmamed, Noelia

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2025; Vol. 53, Issue , pp. -. DOI: 10.1016/j.ctro.2025.100981

  • Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severit

    Author: Patel, Partha; Rahman, Syed Minhaj; Behroozian, Tara; Finkelstein, Samuel; Kanee, Lauren; Zhang, Elwyn; Banerjee, Suvam; Aquilano, Michele; Bonomo, Pierluigi; Chan, Raymond J.; Chow, Edward; Chan, Adrian Wai; Kwan, Jennifer Yin Yee; Lee, Shing Fung; Wong, Henry; van den Hurk, Corina; Trombetta, Mark; Wolf, Julie Ryan

    Journal: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2025; Vol. 53, Issue , pp. -. DOI: 10.1016/j.ctro.2025.100977